CBRE vs BIIB Comparison

CBRE is the world's largest commercial real estate services and investment firm, providing brokerage, leasing, facilities and project management, valuation, mortgage services, and investment management to occupiers and investors across every major property type. The firm in its current form traces its lineage to a 1998 merger of CB Commercial with UK-based Richard Ellis International, whose own history goes back to London in the 1770s. Today, CBRE employs more than 140,000 people serving clients across more than 250 markets in over 100 countries.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).